Diseases

T420X5D

Adverse effect of hydantoin derivatives, subsequent encounter

T421X5A

Adverse effect of iminostilbenes, initial encounter

T421X5S

Adverse effect of iminostilbenes, sequela

T421X5D

Adverse effect of iminostilbenes, subsequent encounter

T45AX5A

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter

T45AX5S

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela

T45AX5D

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

T50Z15A

Adverse effect of immunoglobulin, initial encounter

T50Z15S

Adverse effect of immunoglobulin, sequela

T50Z15D

Adverse effect of immunoglobulin, subsequent encounter

T410X5A

Adverse effect of inhaled anesthetics, initial encounter

T410X5S

Adverse effect of inhaled anesthetics, sequela

T410X5D

Adverse effect of inhaled anesthetics, subsequent encounter

T383X5A

Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter

T383X5S

Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela

T383X5D

Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter

T411X5A

Adverse effect of intravenous anesthetics, initial encounter

T411X5S

Adverse effect of intravenous anesthetics, sequela

T411X5D

Adverse effect of intravenous anesthetics, subsequent encounter

T454X5A

Adverse effect of iron and its compounds, initial encounter

T454X5S

Adverse effect of iron and its compounds, sequela

T454X5D

Adverse effect of iron and its compounds, subsequent encounter

T494X5A

Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter

T494X5S

Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela

T494X5D

Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter

T413X5A

Adverse effect of local anesthetics, initial encounter

T413X5S

Adverse effect of local anesthetics, sequela

T413X5D

Adverse effect of local anesthetics, subsequent encounter

T490X5A

Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter

T490X5S

Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela

T490X5D

Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter

T492X5A

Adverse effect of local astringents and local detergents, initial encounter

T492X5S

Adverse effect of local astringents and local detergents, sequela

T492X5D

Adverse effect of local astringents and local detergents, subsequent encounter

T501X5A

Adverse effect of loop [high-ceiling] diuretics, initial encounter

T501X5S

Adverse effect of loop [high-ceiling] diuretics, sequela

T501X5D

Adverse effect of loop [high-ceiling] diuretics, subsequent encounter

T363X5A

Adverse effect of macrolides, initial encounter

T363X5S

Adverse effect of macrolides, sequela

T363X5D

Adverse effect of macrolides, subsequent encounter

T403X5A

Adverse effect of methadone, initial encounter

T403X5S

Adverse effect of methadone, sequela

T403X5D

Adverse effect of methadone, subsequent encounter

T43655A

Adverse effect of methamphetamines, initial encounter

T43655S

Adverse effect of methamphetamines, sequela

T43655D

Adverse effect of methamphetamines, subsequent encounter

T43635A

Adverse effect of methylphenidate, initial encounter

T43635S

Adverse effect of methylphenidate, sequela

T43635D

Adverse effect of methylphenidate, subsequent encounter

T500X5A

Adverse effect of mineralocorticoids and their antagonists, initial encounter

T500X5S

Adverse effect of mineralocorticoids and their antagonists, sequela

T500X5D

Adverse effect of mineralocorticoids and their antagonists, subsequent encounter

T425X5A

Adverse effect of mixed antiepileptics, initial encounter

T425X5S

Adverse effect of mixed antiepileptics, sequela

T425X5D

Adverse effect of mixed antiepileptics, subsequent encounter

T50A25A

Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter

T50A25S

Adverse effect of mixed bacterial vaccines without a pertussis component, sequela

T50A25D

Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter

T431X5A

Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter

T431X5S

Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela

T431X5D

Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter

T50915A

Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter

T50915S

Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela

T50915D

Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter

T495X5A

Adverse effect of ophthalmological drugs and preparations, initial encounter

T495X5S

Adverse effect of ophthalmological drugs and preparations, sequela

T495X5D

Adverse effect of ophthalmological drugs and preparations, subsequent encounter

T400X5A

Adverse effect of opium, initial encounter

T400X5S

Adverse effect of opium, sequela

T400X5D

Adverse effect of opium, subsequent encounter

T384X5A

Adverse effect of oral contraceptives, initial encounter

T384X5S

Adverse effect of oral contraceptives, sequela

T384X5D

Adverse effect of oral contraceptives, subsequent encounter

T48995A

Adverse effect of other agents primarily acting on the respiratory system, initial encounter

T48995S

Adverse effect of other agents primarily acting on the respiratory system, sequela

T48995D

Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter

T478X5A

Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter

T478X5S

Adverse effect of other agents primarily affecting gastrointestinal system, sequela

T478X5D

Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter

T46995A

Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter

T46995S

Adverse effect of other agents primarily affecting the cardiovascular system, sequela

T46995D

Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter

T471X5A

Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter

T471X5S

Adverse effect of other antacids and anti-gastric-secretion drugs, sequela

T471X5D

Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter

T485X5A

Adverse effect of other anti-common-cold drugs, initial encounter

T485X5S

Adverse effect of other anti-common-cold drugs, sequela

T485X5D

Adverse effect of other anti-common-cold drugs, subsequent encounter

T43295A

Adverse effect of other antidepressants, initial encounter

T43295S

Adverse effect of other antidepressants, sequela

T43295D

Adverse effect of other antidepressants, subsequent encounter

T462X5A

Adverse effect of other antidysrhythmic drugs, initial encounter

T462X5S

Adverse effect of other antidysrhythmic drugs, sequela

T462X5D

Adverse effect of other antidysrhythmic drugs, subsequent encounter

T426X5A

Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter

T426X5S

Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela

T426X5D

Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter

T465X5A

Adverse effect of other antihypertensive drugs, initial encounter

T465X5S

Adverse effect of other antihypertensive drugs, sequela

T465X5D

Adverse effect of other antihypertensive drugs, subsequent encounter